earnings

NASDAQ · ATRA
Atara Biotherapeutics, Inc.
Healthcare · Biotechnology
$10.11
Down-$0.40 (-3.96%)
Updated Sep 17, 2026, 9:32 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 128.72M
- P/E ratio
- 37.58
- Dividend yield
- 0.00%
- 52-week range
- $4.30 – $12.45
- Volume
- 116.75K
- Avg. volume
- 71.88K
Price performance
ATRA price history
1M range · 20 trading sessions · Daily adjusted prices
ATRA closed at $10.11 after 20 trading sessions, up 5.31% for the selected period.
- Last close
- $10.11
- Period change
- +5.31%
- Period low
- $8.90
- Period high
- $10.23
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $9.50 | $10.37 | $9.07 | $10.11 | 116.75K |
| Sep 15, 2026 | $9.21 | $9.88 | $8.92 | $9.44 | 56.06K |
| Sep 14, 2026 | $9.09 | $9.71 | $9.07 | $9.25 | 50.85K |
| Sep 11, 2026 | $10.00 | $10.00 | $9.38 | $9.38 | 16.03K |
| Sep 10, 2026 | $9.94 | $9.94 | $9.52 | $9.89 | 23.21K |
| Sep 9, 2026 | $10.27 | $10.43 | $9.76 | $9.91 | 68.51K |
| Sep 8, 2026 | $10.60 | $11.33 | $10.23 | $10.23 | 106.94K |
| Sep 4, 2026 | $9.45 | $9.95 | $9.25 | $9.76 | 135.66K |
| Sep 3, 2026 | $9.49 | $9.53 | $9.00 | $9.53 | 25.28K |
| Sep 2, 2026 | $9.08 | $9.48 | $9.08 | $9.44 | 20.9K |
| Sep 1, 2026 | $8.96 | $9.18 | $8.80 | $9.02 | 51.95K |
| Aug 31, 2026 | $9.09 | $9.29 | $8.83 | $8.90 | 30.24K |
| Aug 28, 2026 | $9.18 | $9.21 | $8.90 | $9.20 | 15.35K |
| Aug 27, 2026 | $9.38 | $9.60 | $9.165 | $9.25 | 26.95K |
| Aug 26, 2026 | $9.65 | $9.84 | $9.38 | $9.38 | 63.75K |
| Aug 25, 2026 | $9.57 | $10.02 | $9.5379 | $9.84 | 48.51K |
| Aug 24, 2026 | $9.57 | $9.66 | $9.31 | $9.46 | 23.97K |
| Aug 21, 2026 | $9.46 | $9.89 | $9.15 | $9.70 | 27.09K |
| Aug 20, 2026 | $9.60 | $9.74 | $9.14 | $9.38 | 28.02K |
| Aug 19, 2026 | $8.85 | $9.74 | $8.2764 | $9.60 | 79.15K |
Latest ATRA news
The latest Smart Investors Daily articles mentioning ATRA.
Stock researchCompany · Financials
Loading stock research…

